Christopher Yonan

Christopher Yonan has a strong background in biologics process and product development, with extensive experience in technical operations and process development for biopharmaceutical companies. Christopher is currently working as the Vice President of Technical Operations at Outlook Therapeutics, Inc. since April 2019. Prior to this, they served as the Executive Director of Process & Analytical Development at Oncobiologics Inc. from July 2017 to April 2019, where they led a development organization responsible for the development of robust manufacturing processes for biosimilar monoclonal antibodies. Christopher also held the role of Director of Purification Development at Oncobiologics Inc. from August 2011 to July 2017, where they were accountable for the development of downstream clinical and commercial manufacturing processes for protein-based therapeutics. Christopher Yonan began their career at Bristol-Myers Squibb in October 2003, where they worked as a Group Leader in Biologics Process & Product Development until August 2011.

Christopher Yonan obtained a Ph.D in Biochemistry from Temple University, where they studied from 1997 to 2003. Prior to that, they earned a Bachelor of Science degree in Biology from Wheaton College, completing their studies from 1990 to 1994.